INTRODUCTION
The frequency of arterial degeneration diseases, especially atherosclerosis, is constantly increasing due to a currently worldwide aging human population. Atherosclerosis is a disease which causes gradual thickening and elasticity loss of the arterial wall, and simultaneous stenosis and/ or occlusion of luminar [1] .
Chronic arterial insufficiency (CAI) results in stenotic-occlusive disease of tissues and organs of vascularized arterial disorders. CAI of the lower extremities represents a significant medical and socio-economic problem due to a high incidence of morbidity (intermittent claudication, pain at rest, muscular atrophy, ulcerations and gangrene), invalidity (limitations of active movement and amputation of the devitalized part of the extremity) and mortality.
Depending on the localization of stenoticocclusive lesion and the possibility of the establishment of collateral circulation results in complex haemodynamic disorders. Such lesions determine the rapidity of progression and the degree of CAI severity leasing to hypoxemia and resultant disorders aerobic cell metabolism of limb tissues, due to the reduction in the supply of arteries with oxygen [2] .
By the end of the 20 th century it became obvious that empirical means have not given valid results in lower extremity perfusion, because of the loss of their sensitivity and specifics. The necessary improvement in the research of instruments and techniques resulted in the discovery of numerous and different objective methods which could be applied in the diagnostics of peripheral vascular diseases [3] . Among the tested invasive methods, beside electronic oscillometry with oscillography, plehyismography, capillaroscopy, thermometry with thermography, Doppler echosonography and its modality (CW Doppler, duplex scanning-B mode and triplex scanning colour Doppler), in numerous worldwide conducted clinical studies pulse oximetry has shown to be invaluable in the determination of the stage of peripheral ischemia [4, 5] .
Historical sources of pulse oximetry go as far as the period when colour spectrum and Isaac Newton's sunlight were disclosed in 1666, with the first description of haemoglobin in 1860. In 1874 Karl von Vierordt tried to measure blood oxygen saturation of the human hand [6] .
SummARy
Introduction Chronic arterial insufficiency (CAI) of lower extremities is important socioeconomical and healthcare problem, due to its high incidence of morbidity, disability and mortality. Objective The aim of our work was to determine the diagnostic importance of pulse oximetry in the early detection of stage of lower extremities CAI based on peripheral arterial oxygen saturation of haemoglobin (SpO 2 [7] . In 1935 Matthes constructed the first appliance for continuous measuring of the human blood oxygen saturation using the two light sheaves of different wavelengths, red-sensitive to oxygenation changes and green-insensitive, so as to compensate for the changes in tissue thickness, haemoglobin type and light intensity [8] .
The first pulse oximeter was constructed by the Japanese physiologist and bioengineer Takuo Aoyagi in 1973. He concluded that the variation of tissue arterial blood volume may be useful for obtaining a signal depending only on pulse characteristics of arterial blood, which can be used for measuring arterial oxygen saturation [9] . Further development of pulse oximetry in this country occurred in early 1980 conducted by Biox (Ohmeda) and Nellcor companies by the application of microprocessor technologies which improved the performance of oximetry [10] . Recent dated oximetry use light emitting diodes (LED) which emit red and infrared light in the sensor for the ear and finger. Since then, a few more companies have entered the field of investigating pulse oximetry, thus, large achievements were accomplished to make the signal of the oximeter exceptionally resistant to the surrounding influence [11] .
The principle of measuring haemoglobin oxygen saturation (SpO 2 ) by pulse oximetry is based on spectrophotometry principles according to the Beer-Lambert law from 1851, which linked a concentration solution substance with light transmitted intensity through solution. Pulse oximetry non-invasively measures arterial blood oxygen saturation and pulse frequency of pulse with the confidence interval of ±2-3 for SpO 2 values from 70-100%, and ±3 for SpO 2 values from 50-70%, indicating the desaturation of oxihaemoglobin prior to the colour of the patient's skin becomes evident [12] .
OBjECTIvE
The aim of the study was to examine and evaluate the following: 1. gender and age of the patient in the stages of functional (Fontaine stage IIa and IIb) and critical ischemia (Fontaine stage III and IV) of CAI of lower extremities; 2. diagnostic values of pulse oximetry in early detection and determination of the stage of CAI of the lower extremities; and 3. reliability of stage diagnostics of pulse oximetry in relation to colour Doppler duplex scan echosonography in patients with CAI of the lower extremities.
METHODS
The prospective clinical study involved a group of 50 patients, CAI of the lower extremity was determined on the basis of clinical findings and colour Doppler duplex scan echosonography results. The colour Doppler duplex scan echosonography imaging of the lower extremity arteries was performed using the apparatus SIEMENS Sienna Sonoline (Diagnostic Ultrasound System, Siemens mead System, Inc., Issaquah, WA 988029-7002, USA) with a probe LINEAR ARREY 7.5 MHz L 40. Using the conventional method (single-gate) and colour Doppler duplex scan (multi-gate), the presence and localization of stenosis, the segmental predominance (with multisegmental forms) and the degree of progression of stenotic-occlusive lesions were verified.
The control group consisted of 50 patients treated at the Surgical Clinic due to other surgical diseases, without clinically manifested signs and symptoms of CAI of lower extremities. There were 25 male and 25 female (ratio of 1:1). The average age of patients was 55.5±4.8 years.
The colour Doppler duplex scan ultrasonography was used to determine the localization of stenotic-occlusive lesion in the study group of patients in the stage of functional ischemia and showed that the most frequent involvement was the femoropopliteal segment disclosed in 12 patients (48%), multisegmental localization was revealed in 7 patients (28%), the aorto-iliac segment in 5 patients (20%) and the tibio-peroneal segment was seen in one patient (4%). In the studied group of patients in the stage of critical ischemia colour Doppler duplex scan echosonography imaging showed that the most frequent involvement was the femoropopliteal segment shown in 13 (52%), the aorto-iliac segment in 6 (24%), multisegment localization in 7 (28%) and the tibio-peroneal segment in 2 patients (8%).
The determination of SpO 2 was performed in all patients using pulse oximetry as a part of monitoring (DATEX the ACE/3™ Nellcor® Compatible Saturation Module M-NSAT, Anaesthesia Monitor), applied after the patients were acclimatized to temperature from 22-23°C. The sensor Datex SpO 2 FingerSat Nellcor® OXISENSOR, Sensor SAS-F4, (DATEX, Division of Instrumentarium Corp. Finland, 1995.) was used on the patient's toe at rest in supine position (Figure 1) . Pulse oximetry measurements of SpO 2 rating 95% ±2 and higher were taken to be the normal value for toe nail capillaries in patients with the lower extremity disease; while the lower values of SpO 2 indirectly marked the degree of compromised major arterial blood flow in patients with stenotic-occlusive specific lesion stage of CAI of the lower extremities.
The statistical analysis of data was carried out by analitical and descriptive methods, while the data were classified and graphically presented (Microsoft Word 2003). Using the comparative method the analyzed investigation results of the study and control groups underwent analysis. Significance of the data was tested using the Student t-test.
RESULTS
The study group with functional ischemia (Fontaine stage I, IIa and IIb stage) consisted of 25 patients: 15 men (60%) with an average age of 61.4±7.3 years and 10 women (40%) with an average age of 58.6±5.2 years (p<0.1); with the man to female ratio of 1.5:1 (Graph 1).
The study group with critical ischemia (Fontaine stage III and IV) consisted of 25 patients: 17 men (68%), average age of 64.8±5.2 years, and 8 women (32%), average age 59.5 ±4.8 years (p<0.05); with man to female ratio of 2.12:1 (p<0.05) (Graph 2).
In the study group Fontaine stage I with critical ischemia, SpO 2 of the toe nail capillaries of the involved lower extremity rated 95.33±1.41%, while in those with Fontaine stage IIa it was 92.14±2.27% and Fontaine stage IIb it was 79.67±2.73%; in the study group Fontaine stage III with critical ischemia (Figure 2 ), stage Fontaine IV it was 47.67±6.16%, while in 3 patients with gangrenous foot and fingers SpO 2 was not possible to be measured (Graph 3). In the control group patients SpO 2 was 99.44±0.88%. Measuring of SpO 2 of toe nail capillaries using pulse oximetry is significantly different depending on the stage of CAI of the lower extremities. In all groups we determined statistically a significant progressive decrease of SpO 2 values in correlation with the severity of the disease (p<0.01, between stages).At the same time, the patients with the lightest form of the disease (stage I of functional ischemia) had considerably lower SpO 2 value in relation to the control group (p<0.01).
DISCUSSION
CAI of lower extremities is clinically manifested by certain clinical features of functional and critical ischemia, which dependents on the localization of stenotic-occlusive lesions of the arteries, their size, extent of involvement and the development of collateral arterial network.
In 1945 the French surgeon René Fontaine made a classification of stages of CAI of lower extremities according to the severity of lower extremity CAI [13] . The original classification according to the progression or regression of the disease was based on illness history data and it is still in use up-to-date. First stage is marked by uncharacteristic initial problems involving the lower limbs (coldness, numbness, fatigue), second stage is characterized by intermittent claudication symptoms (intensive spasm in sporadic muscle groups of legs) with the passed claudication distance of over 100 meters in stage IIa and shorter than 100 meters in stage IIb. Third stage is presented by pains during night and at rest. Fourth stage presents with ulcerations and gangrene of feet and lower extremities below knees.
In 1995 the European Committee for Consensus Document on Critical Limb Ischemia proposed and modified Fontaine's Classification by including into each illness stage, beside clinical evaluation, the evaluation of pathophysiological onset mechanism and the findings of blood flow obtained by ultrasonographic and plethysmographic methods, the findings of metabolic oxygen concentration in tissues by oximetry with the determination of perfusion pressure by Doppler [12] .
Modern epidemiological studies have shown that general population has 5% of men and 2.5% of women over the average ages of 60 years with the initial development of the symptoms of lower extremity CAI. The prevalence of intermittent claudication and functional ischemia symptoms in men younger than 60 years is about 1-2%, while it is higher in men older than 60 years (5%) [13] . Our group confirms the higher frequency of clinical manifestations of CAI of lower extremities in the 7 th decade of life and in older age population with a gradual decrease in the frequency in younger age groups, as well as a mild predomination of men in both study subgroups (in stages of functional ischemia, with man to female ratio of 1.5:1, and in stages of critical ischemia, with man to female ratio of 2.12:1. In patients older than 70 years the frequency of CAI of the lower extremities is almost identical in men and women [14] . In the study group there were no patients younger than 40 years, which also confirms the study of Criqui et al. on the incidence of clinical manifestion of CAI of lower extremities [15] .
The use of pulse oximetry as a noninvasive method for measuring SpO 2 saturations in the evaluation of peripheral arterial occlusive diseases has begun in the last 15 years. Data obtained by this study has confirmed the reduction of SpO 2 values in tissues which vascularize the arteries inflicted by stenotic-atherosclerosis [16] [17] [18] [19] [20] . In a study by Joyce, pulse oximetry investigation of SpO 2 of the foot dorsum and posterior tibial area in patients with peripheral arterial-occlusive disease, intermittent claudication and critical ischemia, indicates that there is a significant correlation between the decreased SpO 2 and the stage and the level of lower extremity arterial occlusion [21] .
Findings of SpO 2 obtained by pulse oximetry are also in considerable correlation with colour Doppler ultrasonography and with Doppler duplex scan imaging results of peripheral vascular disease, indicating the severity of the stage of stenotic process. In a study by Couse et al. similar results were obtained when diagnosis was made in patients with non-critical peripheral vascular insufficiency by experimental provocation of a specific stage of occlusion applying tourniquet pressure at a specific level of the lower extremity; indirect data on the transient major artery of the lower extremity obtained by ultrasonography colour Doppler duplex scan were compared with the findings of pulse oximetry [22] . Our study also confirmed positive correlation of pulse oximetry findings with the results of colour Doppler duplex scan ultrasonography in patients with a stage of functional and critical ischemia.
By the analysis of pulse oximetry investigation performed in our study with patients in a stage of functional and critical ischemia of CAI of lower extremities by determining SpO 2 in toe nail capillaries the following results were reached: in Fontaine stage I of functional ischemia SpO 2 was 95.33±1.41%, in Fontaine stage IIa was 92.14 ±2.27% and in Fontaine stage IIb stage it was 79.67±2.73%, in Fontaine stage III of critical ischemia oxygen saturation of haemoglobin was 62.54±4.39%, in Fontaine IV stage it was 47.67±6.16%, in patients with gangrene of the foot and finger it was not possible to measure SpO 2 . In control group patients SpO 2 was 99.44±0.88%. Previously mentioned lowered pulse oximetry values had a significant positive correlation with the stage of CAI of lower extremities, which confirms the positive diagnostic value in the evaluation of patients.
The method of pulse oximetry is not only simple and rapid to use, but it is also a noninvasive method, which does not require calibration and is highly precise. Recent technical solutions of the device enable easy transport and application under all conditions. Later technical development of pulse oximetry involves the solution of the problem with respect to modifications of the skin sensor of pulse oximetry which will extend the spectre of its application and the precision of measurements by reducing sensitivity of the signal to movements and improvement of the sensitivity in patients with darker pigmentation and dishaemoglobinemia [23] .
In future, pulse oximetry will have diagnostic value in the determination of stages of functional and critical ischemia of CAI of lower extremities, because of the high level of precision and simplicity in the use of the instrument. SpO 2 values of lower extremity distal tissues can be applied for estimating the outcomes of planned surgical reconstructive procedures and determining the safe level of the amputation of extremities in patients with critical ischemia and developed tissue necrosis and gangrene [24] .
CONCLUSION
Using non-invasive SpO 2 measurement by applying pulse oximetry has shown the reduction of oxygen values in tissues that vascularize arteries with stenotic-occlusive process. It confirms its diagnostic value in the determination of the stage of CAI of lower extremities. By SpO 2 values, pulse oximetry reflects the stage and severity of CAI and has shown diagnostic precision in comparison with colour Doppler duplex scan ultrasonography in patients with CAI of lower extremities.
